Germany, Oct. 7 -- Evonik has won the 2026 CPHI Pharma Award in the "Digital Transformation" category for its Self Driving Labs. The globally available CDMO service combines artificial intelligence, automation and chemical expertise in a closed-loop platform that autonomously designs, executes and evaluates experiments for active pharmaceutical ingredient (API) process development.Developing manufacturing processes for APIs is becoming more complex as pipelines expand beyond small molecules to modalities such as peptides and oligonucleotides. Conventional process development relies on sequential, manual experiments that can take weeks, produce limited analytical data and depend heavily on expert judgement. Once a process has advanced into l...